Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IL-9 sensitizes human Th2 cells to pro-inflammatory IL-18 signals in atopic dermatitis.
Schärli S, Luther F, Di Domizio J, Hillig C, Radonjic-Hoesli S, Thormann K, Simon D, Møller Rønnstad AT, Ruge IF, Fritz BG, Bjarnsholt T, Vallone A, Kezic S, Menden MP, Roesner LM, Werfel T, Thyssen JP, Eyerich S, Gilliet M, Bertschi NL, Schlapbach C. Schärli S, et al. Among authors: radonjic hoesli s. J Allergy Clin Immunol. 2024 Nov 7:S0091-6749(24)01171-0. doi: 10.1016/j.jaci.2024.10.027. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39521283 Free article.
Comparison of patch testing Brazilian (Green) propolis and Chinese (poplar-type) propolis: Clinical epidemiological study using data from the Information Network of Departments of Dermatology (IVDK).
Piontek K, Radonjic-Hoesli S, Grabbe J, Drewitz KP, Apfelbacher C, Wöhrl S, Simon D, Lang C, Schubert S. Piontek K, et al. Among authors: radonjic hoesli s. Contact Dermatitis. 2024 Oct 5. doi: 10.1111/cod.14701. Online ahead of print. Contact Dermatitis. 2024. PMID: 39367763
Dupilumab-associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation.
Thormann K, Lüthi AS, Deniau F, Heider A, Cazzaniga S, Radonjic-Hoesli S, Lehmann M, Schlapbach C, Herzog EL, Kreuzer M, Zinkernagel MS, Akdis CA, Zysset-Burri DC, Simon HU, Simon D. Thormann K, et al. Among authors: radonjic hoesli s. Allergy. 2024 Apr;79(4):937-948. doi: 10.1111/all.16045. Epub 2024 Feb 5. Allergy. 2024. PMID: 38317432 Free article.
PPAR-γ regulates the effector function of human T helper 9 cells by promoting glycolysis.
Bertschi NL, Steck O, Luther F, Bazzini C, von Meyenn L, Schärli S, Vallone A, Felser A, Keller I, Friedli O, Freigang S, Begré N, Radonjic-Hoesli S, Lamos C, Gabutti MP, Benzaquen M, Laimer M, Simon D, Nuoffer JM, Schlapbach C. Bertschi NL, et al. Among authors: radonjic hoesli s. Nat Commun. 2023 Apr 29;14(1):2471. doi: 10.1038/s41467-023-38233-x. Nat Commun. 2023. PMID: 37120582 Free PMC article.
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy.
Sidler D, Born A, Schietzel S, Horn MP, Aeberli D, Amsler J, Möller B, Njue LM, Medri C, Angelillo-Scherrer A, Borradori L, Seyed Jafari SM, Radonjic-Hoesli S, Chan A, Hoepner R, Bacher U, Mani LY, Iype JM, Suter-Riniker F, Staehelin C, Nagler M, Hirzel C, Maurer B, Moor MB. Sidler D, et al. Among authors: radonjic hoesli s. RMD Open. 2022 Mar;8(1):e002166. doi: 10.1136/rmdopen-2021-002166. RMD Open. 2022. PMID: 35361691 Free PMC article.
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study.
Moor MB, Suter-Riniker F, Horn MP, Aeberli D, Amsler J, Möller B, Njue LM, Medri C, Angelillo-Scherrer A, Borradori L, Radonjic-Hoesli S, Seyed Jafari SM, Chan A, Hoepner R, Bacher VU, Mani LY, Iype JM, Hirzel C, Maurer B, Sidler D. Moor MB, et al. Among authors: radonjic hoesli s. Lancet Rheumatol. 2021 Nov;3(11):e789-e797. doi: 10.1016/S2665-9913(21)00251-4. Epub 2021 Sep 7. Lancet Rheumatol. 2021. PMID: 34514436 Free PMC article.
Eosinophils in skin diseases.
Radonjic-Hoesli S, Brüggen MC, Feldmeyer L, Simon HU, Simon D. Radonjic-Hoesli S, et al. Semin Immunopathol. 2021 Jun;43(3):393-409. doi: 10.1007/s00281-021-00868-7. Epub 2021 Jun 7. Semin Immunopathol. 2021. PMID: 34097126 Free PMC article. Review.
Successful treatment of refractory folliculitis decalvans with apremilast.
Fässler M, Radonjic-Hoesli S, Feldmeyer L, Imstepf V, Pelloni L, Yawalkar N, de Viragh PA. Fässler M, et al. Among authors: radonjic hoesli s. JAAD Case Rep. 2020 Aug 20;6(10):1079-1081. doi: 10.1016/j.jdcr.2020.08.019. eCollection 2020 Oct. JAAD Case Rep. 2020. PMID: 32995449 Free PMC article. No abstract available.
15 results